US Stock MarketDetailed Quotes
HEPA Hepion Pharmaceuticals
- 0.7600
- -0.0590-7.20%
Close Aug 23 16:00 ET
- 0.7926
- +0.0326+4.29%
Post 20:02 ET
4.41MMarket Cap-118P/E (TTM)
0.8175High0.7312Low42.23KVolume0.8100Open0.8190Pre Close32.63KTurnover0.80%Turnover RatioLossP/E (Static)5.80MShares7.850052wk High2.36P/B4.01MFloat Cap0.552552wk Low--Dividend TTM5.28MShs Float8792.0000Historical High--Div YieldTTM10.54%Amplitude0.5525Historical Low0.7720Avg Price1Lot Size
About Hepion Pharmaceuticals Company
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.
Company Profile
SymbolHEPA
Company NameHepion Pharmaceuticals
Listing DateFeb 27, 2015
Founded2013
CEOMr. John Patrick Brancaccio
MarketNASDAQ
Employees22
Fiscal Year Ends12-31
Address399 Thornall Street,1st Floor
CityEdison
ProvinceNew Jersey
CountryUnited States of America
Zip Code08837
Phone1-732-902-4000
Websitehttp://www.hepionpharma.com
Company Executives
- Name
- Position
- Salary
- John Patrick Brancaccio
- Interim Chief Executive Officer and Interim Chief Financial Officer
- 81.00K
- Michael Purcell
- Director
- --
- Dr. Kaouthar Lbiati, M.D.
- Independent Director
- 80.50K
- Dr. Timothy Block, PhD
- Independent Director
- 72.90K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg